Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide C pseudogene 4 (SNRPCP4)

Target
SNRPCP4
Molecular classification
Pseudogene
01

Overview

Small nuclear ribonucleoprotein polypeptide C pseudogene 4" (SNRPCP4) refers to a *pseudogene* derived from the gene encoding the C polypeptide of small nuclear ribonucleoproteins (snRNPs), which are components of the spliceosome machinery responsible for precursor mRNA splicing. Pseudogenes are non-functional segments of DNA that arise from gene duplication or retrotransposition events but typically do not encode functional proteins. There is no evidence that this pseudogene produces a functional protein or is involved in biological processes or diseases. It is not considered a therapeutic target, receptor, enzyme, transporter, or biologically active molecule relevant to drug discovery efforts. No known drugs, biomarkers, or safety concerns are associated with this pseudogene. **Key points:** - SNRPCP4 is a pseudogene, not an active gene or protein, and thus is not a drug target or receptor. - No biological, molecular, or clinical function has been assigned to SNRPCP4 in the available literature. - There are no established aliases, interacting drugs, or safety/toxicological considerations. - There is no evidence of a role in any disease, nor any reported use as a biomarker. **Note on potential confusion:** The query may stem from confusion with *SNRPC* (small nuclear ribonucleoprotein polypeptide C), which is a functional protein component of the spliceosome, or with small nuclear RNAs (snRNAs) and their role in splicing and neurodevelopmental disorders[1][2]. However, SNRPCP4 specifically denotes a non-functional pseudogene, not those active elements.

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide C pseudogene 4 (SNRPCP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 4 (SNRPCP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call